Completed NCT01606228
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries
Sponsor Janssen Pharmaceutica
Condition Schizophrenia Terminated NCT03643159
This study was terminated in the United States. It focuses on depression.
Multiple locations, including Santa Rosa Depression, Bipolarity, ... Drug From 18 Years to 63 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Depression, Bipolarity, ... Completed NCT07305779
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
In Overland Park Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT07002385
This study is completed in China. It focuses on depression.
In Wenzhou Depression, Anxiety Behavioral Over 60 Years
Countries China
Sponsor Wenzhou Seventh People's Hospital
Condition Depression, Anxiety Completed NCT01566162
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Schizophrenia Drug Over 18 Years
Countries United States, France, Italy, ...
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT00208156
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including San Diego Depression, Schizophrenia Drug From 18 Years to 75 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Depression, Schizophrenia Completed NCT00130676
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Pico Rivera Depression, Schizophrenia Drug From 18 Years to 75 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Depression, Schizophrenia Completed NCT00128479
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Depression, Schizophrenia Drug From 18 Years to 75 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Depression, Schizophrenia Completed NCT04025671
This summary needs review. Please check the official study record and contact the research team for details.
In Syracuse Addiction Device i A study involving a tool, app, wearable, test, or medical device. Over 18 Years
Countries United States
Sponsor State University of New York - Upstate Medical University
Condition Addiction Completed NCT01399112
This summary needs review. Please check the official study record and contact the research team for details.
In Glen Oaks Schizophrenia Behavioral From 15 Years to 30 Years
Countries United States
Sponsor Northwell Health
Condition Schizophrenia Completed NCT04148521
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Albemarle Addiction, Depression, ... Behavioral Over 18 Years
Countries United States
Sponsor Wake Forest University Health Sciences
Condition Addiction, Depression, ... Completed NCT04686864
This study is completed in Canada. It focuses on Eating disorders.
In Hamilton Eating disorders Behavioral From 18 Years to 100 Years
Countries Canada
Sponsor McMaster University
Condition Eating disorders